What's breaking now, across thousands of outlets.
Die Börse feiert den Studienerfolg von Moderna und Merck. Ein personalisierter Krebsimpfstoff rückt näher und könnte ein Gamechanger für die Krebsmedizin werden.
We haven't written up this one. Handelsblatt has the full story — the link below goes straight to it.
PrEP is an HIV prevention intervention for people who do not have HIV but may be at risk of acquiring the virus. It involves the use of medicines to reduce the risk of HIV infection.
Neither Daszak nor Keusch has been charged with a crime.
The clearance of Genglycos for a rare glycogen storage disease gives Ultragenyx a sellable voucher and momentum ahead of an eagerly anticipated study readout.
Musician, who revealed first Hodgkin's lymphoma diagnosis in 2013, says cancer's return won't slow him down
There is no cure for dementia, and as the condition progresses, the patient may not be able to recognize loved ones.
